Received May 13, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
patient only received the liquid part of the vaccine and not the powder; patient only received the liquid part of the vaccine and not the powder; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis. On 06-MAY-2026, the patient received Shingrix. On 06-MAY-2026, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: patient only received the liquid part of the vaccine and not the powder) and inappropriate dose of vaccine administered (Verbatim: patient only received the liquid part of the vaccine and not the powder). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 06-MAY-2026 The batch number was not provided upon follow up with the reporter.